人乳头瘤病毒疫苗接种率:2013-2015年美国印第安青少年接种率上升
研究基于2013年6月至2015年6月数据,在五个印第安卫生服务区域的印第安卫生服务、部落运营和城市印第安(I/T/U)医疗机构中,识别最佳实践与干预机构,访谈医务人员并实施低成本循证干预。结果显示,干预机构HPV疫苗首剂和末剂平均覆盖率分别提高24%和22%,提示针对接种流程与患者及提供者教育的定制化多层面方法可能提高HPV疫苗覆盖率。
要点
- 最佳实践机构基线首剂HPV疫苗覆盖率均值为78%,干预机构为46%。
- 最佳实践机构基线第三剂覆盖率均值为48%,干预机构为19%。
- 干预机构实施低成本循证策略后,HPV疫苗启动和完成平均覆盖率分别提高24%和22%。
核心结论
- 针对疫苗接种流程以及患者和提供者教育的定制化多层面方法可能提高HPV疫苗覆盖率。
研究设计与样本
- 研究识别了基于基线青少年HPV疫苗覆盖率数据的最佳实践和干预I/T/U医疗机构,访谈医务人员了解接种障碍与促进因素,并协助机构实施干预;覆盖率和访谈数据收集于2013年6月至2015年6月,数据于2015年分析。
- 研究纳入位于五个印第安卫生服务区域内的I/T/U医疗机构。
主要发现
- 最佳实践机构基线首剂HPV疫苗覆盖率均值为78%,干预机构为46%。
- 最佳实践机构基线第三剂覆盖率均值为48%,干预机构为19%。
- 干预机构实施了多项低成本、循证的策略和最佳实践以提高疫苗覆盖率。
- 基线时,多数机构使用电子提供者提醒、有针对接种HPV疫苗的长期医嘱,并在同一次就诊中接种破伤风、白喉和无细胞百日咳疫苗及HPV疫苗。
- 在干预点,HPV疫苗启动和完成平均覆盖率分别提高24%和22%。
关键数值与推荐
- 干预措施包括分析和反馈机构疫苗覆盖率数据、对提供者进行HPV疫苗教育、扩大HPV疫苗可及性、建立或扩大提醒召回和教育努力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although Indian Health Service, tribally-operated, and urban Indian (I/T/U) healthcare facilities have higher human papillomavirus (HPV) vaccine series initiation and completion rates among adolescent patients aged 13-17 years than the general U.S. population, challenges remain. I/T/U facilities have lower coverage for HPV vaccine first dose compared with coverage for other adolescent vaccines, and HPV vaccine series completion rates are lower than initiation rates. Researchers aimed to assist I/T/U facilities in identifying interventions to increase HPV vaccination series initiation and completion rates. STUDY DESIGN: Best practice and intervention I/T/U healthcare facilities were identified based on baseline adolescent HPV vaccine coverage data. Healthcare professionals were interviewed about barriers and facilitators to HPV vaccination. Researchers used responses and evidence-based practices to identify and assist facilities in implementing interventions to increase adolescent HPV vaccine series initiation and completion. Coverage and interview data were collected from June 2013 to June 2015; data were analyzed in 2015. SETTING/PARTICIPANTS: I/T/U healthcare facilities located within five Indian Health Service regions. INTERVENTION: Interventions included analyzing and providing feedback on facility vaccine coverage data, educating providers about HPV vaccine, expanding access to HPV vaccine, and establishing or expanding reminder recall and education efforts. MAIN OUTCOME MEASURES: Impact of evidence-based strategies and best practices to support HPV vaccination. RESULTS: Mean baseline first dose coverage with HPV vaccine at best practice facilities was 78% compared with 46% at intervention facilities. Mean third dose coverage was 48% at best practice facilities versus 19% at intervention facilities. Intervention facilities implemented multiple low-cost, evidence-based strategies and best practices to increase vaccine coverage. At baseline, most facilities used electronic provider reminders, had standing orders in place for administering HPV vaccine, and administered tetanus, diphtheria, and acellular pertussis and HPV vaccines during the same visit. At intervention sites, mean coverage for HPV initiation and completion increased by 24% and 22%, respectively. CONCLUSIONS: A tailored multifaceted approach addressing vaccine delivery processes and patient and provider education may increase HPV vaccine coverage.
引用
- Jacobs-Wingo JL, Jim CC, Groom AV, et al. Human Papillomavirus Vaccine Uptake: Increase for American Indian Adolescents, 2013-2015. Am J Prev Med. 2017. PMID: 28256284. doi:10.1016/j.amepre.2017.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。